RESMED INC — Director's Dealing 2022

Nov 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-11-23

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-23	ResMed Common Stock	A	12389	—	Acquired	113700	Direct
2022-11-23	ResMed Common Stock	F	6911	$224.40	Disposed	106789	Direct

Footnotes

F1: Represents performance-based restricted stock units granted on November 21, 2019. The shares were earned on November 23, 2022, when the compensation committee certified that the performance metrics were met.

F2: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/21/2019.